Page 121 - CIBER-BBN2016-ENG

Most relevant scientific articles
• Crespo L., Hierro-Oliva M., Barriuso S., Vadillo-Rodríguez V., Montealegre M.A., Saldana L. et al. On the interactions of human bone cells with Ti6Al4V thermally oxidized by means of laser shock processing. Biomedical Materials (Bristol). 2016;11(1).
• Cifuentes S.C., Bensiamar F., Gallardo-Moreno A.M., Osswald T.A., González-Carrasco J.L., Benavente R. et al. Incorporation of Mg particles into PDLLA regulates mesenchymal stem cell and macrophage responses. Journal of Biomedical Materials Research - Part A. 2016.
• Bensiamar F., Olalde B., Cifuentes S.C., Argarate N., Atorrasagasti G., González-Carrasco J.L. et al. Bioactivity of dexamethasone-releasing coatings on polymer/magnesium composites. Biomedical Materials (Bristol). 2016;11(5).
• Lieblich M., Barriuso S., Multigner M., González-Doncel G., González-Carrasco J.L. Thermal oxidation of medical Ti6Al4V blasted with ceramic particles: Effects on the microstructure, residual stresses and mechanical properties. Journal of the Mechanical Behavior of Biomedical Materials. 2016;54:173-184.
• Lieblich M., Barriuso S., Ibánez J., Ruiz-de-Lara L., Díaz M., Ocana J.L. et al. On the fatigue behavior of medical Ti6Al4V roughened by grit blasting and abrasiveless waterjet peening. Journal of the Mechanical Behavior of Biomedical Materials. 2016;63:390-398.
Highlights
The group of Bone Physiopathology and Biomaterials has performed a thorough characterization of polymers and metallic alloys, including the study of their microstructure and mechanical properties.
The group has studied the biocompatibility of polymer/Mg composites as well as coating on these materials which were designed to release bioactive molecules. The group has continued their studies on Ti6Al4V alloy modified by means of blasting, thermal treatments, laser shock processing or abrasiveless waterjet peening. The group has progressed in the development of gene switches for the spatial and temporal regulation of therapeutic transgenes. These molecular tools are being targeted for use in several biomedical applications such as vaccination, oncolytic therapy or regenerative medicine. The clinical scientists of the group have continued their participation in clinical trials for therapeutic interventions in bone-related diseases. The group funded its activities by means of grants from MINECO, ISCIII and research contracts with the industry.
BBN
Research Groups 121